These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 477041)

  • 1. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: no requirement for exogenous C5.
    Fuson EW; Walia AS; Cox BA; Lamon EW
    Clin Immunol Immunopathol; 1979 Sep; 14(1):35-46. PubMed ID: 477041
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes.
    Lamon EW; Shaw MW; Goodson S; Lidin B; Walia AS; Fuson EW
    J Exp Med; 1977 Feb; 145(2):302-13. PubMed ID: 833543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
    J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of immunoglobulin- and virus-producing cells in rats infected with Moloney leukemia virus.
    Cremer NE; Taylor DO; Lennette EH
    J Immunol; 1971 Sep; 107(3):689-97. PubMed ID: 4105932
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.
    Weiland E; Mussgay M
    Arch Virol; 1980; 66(1):1-10. PubMed ID: 7436738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on immunity to autochthonous mouse tumors.
    Hellström I; Hellström KE; Pierce GE; Fefer A
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC; Gomard E; Levy JP
    Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
    Veit BC; Feldman JD
    Int J Cancer; 1975 Mar; 15(3):367-76. PubMed ID: 1079791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus.
    Stutman O
    Nature; 1975 Jan; 253(5487):142-4. PubMed ID: 1110765
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 12. Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus.
    Asjö B; Fenyö EM; Spira J; Klein G
    Leuk Res; 1980; 4(1):89-103. PubMed ID: 7412358
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A; Goldstein AL
    Ciba Found Study Group; 1970; 36():3-23. PubMed ID: 4399435
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response.
    Pollack S; Nelson K
    Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic association of the humoral and cellular immune responses of rats to Moloney sarcomas.
    Veit BC; Jones JM; Miller GA; Feldman JD
    Int J Cancer; 1977 Jan; 19(1):97-106. PubMed ID: 401773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of host sex and splenectomy on moloney virus-induced sarcomas.
    Pollack SB
    Int J Cancer; 1971 Sep; 8(2):264-71. PubMed ID: 5133849
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes caused in the homing patterns of chromium 51-labeled lymphoid cells by Moloney sarcoma virus infection.
    Gillette RW; Fox A
    J Natl Cancer Inst; 1977 Jun; 58(6):1621-8. PubMed ID: 864743
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.